BASF To Continue To Supply To GSK, Amarin

News: German chemicals company BASF is to continue supplying API for the US drugmaker Amarin and UK drugmaker GlaxoSmithKline, according to In-Pharma Technologist. BASF's decision comes despite a ruling from the US Food and Drug Administration, which stated that Amarin's Vascepa property, developed as a means to treat cardiovascular patients, should not be approved for use among a wider treatment population.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare
Geography: Germany

Access all of our latest analysis, data and forecasts - request a trial